Literature DB >> 10347212

Glycated phosphatidylethanolamine promotes macrophage uptake of low density lipoprotein and accumulation of cholesteryl esters and triacylglycerols.

A Ravandi1, A Kuksis, N A Shaikh.   

Abstract

Non-enzymatic glycation of low density lipoprotein (LDL) has been suggested to be responsible for the increase in susceptibility to atherogenesis of diabetic individuals. Although the association of lipid glycation with this process has been investigated, the effect of specific lipid glycation products on LDL metabolism has not been addressed. This study reports that glucosylated phosphatidylethanolamine (Glc-PtdEtn), the major LDL lipid glycation product, promotes LDL uptake and cholesteryl ester (CE) and triacylglycerol (TG) accumulation by THP-1 macrophages. Incubation of THP-1 macrophages at a concentration of 100 micrograms/ml protein LDL specifically enriched (10 nmol/mg LDL protein) with synthetically prepared Glc-PtdEtn resulted in a significant increase in CE and TG accumulation when compared with LDL enriched in non-glucosylated PtdEtn. After a 24-h incubation with LDL containing Glc-PtdEtn, the macrophages contained 2-fold higher CE (10.11 +/- 1.54 micrograms/mg cell protein) and TG (285.32 +/- 4.38 micrograms/mg cell protein) compared with LDL specifically enriched in non-glucosylated PtdEtn (CE, 3.97 +/- 0.95, p < 0.01 and TG, 185.57 +/- 3.58 micrograms/mg cell protein, p < 0.01). The corresponding values obtained with LDL containing glycated protein and lipid were similar to those of LDL containing Glc-PtdEtn (CE, 11.9 +/- 1.35 and TG, 280.78 +/- 3.98 micrograms/mg cell protein). The accumulation of both neutral lipids was further significantly increased by incubating the macrophages with Glc-PtdEtn LDL exposed to copper oxidation. By utilizing the fluorescent probe, 1,1'-dioctadecyl-3,3,3', 3'-tetramethylindocarbocyanine perchlorate (DiI), a 1.6-fold increase was seen in Glc-PtdEtn + LDL uptake when compared with control LDL. Competition studies revealed that acetylated LDL is not a good competitor for DiI Glc-PtdEtn LDL (5-6% inhibition), whereas glycated LDL gave an 80% inhibition, and LDL + Glc-PtdEtn gave 93% inhibition of uptake by macrophages. These results indicate that glucosylation of PtdEtn in LDL accounts for the entire effect of LDL glycation on macrophage uptake and CE and TG accumulation and, therefore, the increased atherogenic potential of LDL in hyperglycemia.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10347212     DOI: 10.1074/jbc.274.23.16494

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Amadori-glycated phosphatidylethanolamine, a potential marker for hyperglycemia, in streptozotocin-induced diabetic rats.

Authors:  Phumon Sookwong; Kiyotaka Nakagawa; Ikuko Fujita; Naoki Shoji; Teruo Miyazawa
Journal:  Lipids       Date:  2011-07-06       Impact factor: 1.880

2.  LC-MS/MS analysis of carboxymethylated and carboxyethylated phosphatidylethanolamines in human erythrocytes and blood plasma.

Authors:  Naoki Shoji; Kiyotaka Nakagawa; Akira Asai; Ikuko Fujita; Aya Hashiura; Yasushi Nakajima; Shinichi Oikawa; Teruo Miyazawa
Journal:  J Lipid Res       Date:  2010-04-12       Impact factor: 5.922

3.  Hydrolysis of Phosphatidylcholine-Isoprostanes (PtdCho-IP) by Peripheral Human Group IIA, V and X Secretory Phospholipases A2 (sPLA2).

Authors:  Arnis Kuksis; Waldemar Pruzanski
Journal:  Lipids       Date:  2017-05-20       Impact factor: 1.880

4.  The expression of apolipoprotein B epitopes is normal in LDL of diabetic and end-stage renal disease patients.

Authors:  S Braschi; M Geoffrion; A Nguyen; Y Gaudreau; R W Milne
Journal:  Diabetologia       Date:  2006-04-04       Impact factor: 10.122

5.  Effect of double bond geometry in sphingosine base on the antioxidant function of sphingomyelin.

Authors:  Papasani V Subbaiah; Debajit Sircar; Ravi S Lankalapalli; Robert Bittman
Journal:  Arch Biochem Biophys       Date:  2008-10-12       Impact factor: 4.013

6.  Phospholipids and oxophospholipids in atherosclerotic plaques at different stages of plaque development.

Authors:  Amir Ravandi; Saeid Babaei; Ramsey Leung; Juan Carlos Monge; George Hoppe; Henry Hoff; Hiroshi Kamido; Arnis Kuksis
Journal:  Lipids       Date:  2004-02       Impact factor: 1.880

7.  Human protein S inhibits the uptake of AcLDL and expression of SR-A through Mer receptor tyrosine kinase in human macrophages.

Authors:  Dan Liao; Xinwen Wang; Min Li; Peter H Lin; Qizhi Yao; Changyi Chen
Journal:  Blood       Date:  2008-10-15       Impact factor: 22.113

Review 8.  Lipid peroxidation generates biologically active phospholipids including oxidatively N-modified phospholipids.

Authors:  Sean S Davies; Lilu Guo
Journal:  Chem Phys Lipids       Date:  2014-04-02       Impact factor: 3.329

9.  Dengue virus dominates lipid metabolism modulations in Wolbachia-coinfected Aedes aegypti.

Authors:  Cassandra Koh; M Nurul Islam; Yixin H Ye; Nunya Chotiwan; Barbara Graham; John T Belisle; Konstantinos A Kouremenos; Saravanan Dayalan; Dedreia L Tull; Stephan Klatt; Rushika Perera; Elizabeth A McGraw
Journal:  Commun Biol       Date:  2020-09-18

10.  Non-enzymatic modification of aminophospholipids by carbonyl-amine reactions.

Authors:  Alba Naudí; Mariona Jové; Victòria Ayala; Rosanna Cabré; Manuel Portero-Otín; Reinald Pamplona
Journal:  Int J Mol Sci       Date:  2013-02-05       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.